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Determining the sequence-recognition properties of DNA-binding
proteins and small molecules remains a major challenge. To ad-
dress this need, we have developed a high-throughput approach
that provides a comprehensive profile of the binding properties of
DNA-binding molecules. The approach is based on displaying every
permutation of a duplex DNA sequence (up to 10 positional
variants) on a microfabricated array. The entire sequence space is
interrogated simultaneously, and the affinity of a DNA-binding
molecule for every sequence is obtained in a rapid, unbiased, and
unsupervised manner. Using this platform, we have determined
the full molecular recognition profile of an engineered small
molecule and a eukaryotic transcription factor. The approach also
yielded unique insights into the altered sequence-recognition
landscapes as a result of cooperative assembly of DNA-binding
molecules in a ternary complex. Solution studies strongly corrob-
orated the sequence preferences identified by the array analysis.
chemical genomics  ligand–DNA recognition
A central goal of synthetic biology, chemical biology, andmolecular medicine is the design and creation of synthetic
molecules that can target specific DNA sites in the genome (1, 2).
Such molecules can be harnessed to regulate biological processes
such as transcription, recombination, and DNA repair (1–4). The
greatest success in designing molecules with programmable DNA-
binding specificity has been with polyamides (2). However, a major
hurdle in the design of new classes of sequence-specific DNA-
binding molecules is the inability to comprehensively define the full
range of their DNA sequence-recognition properties, and there-
fore, the inability to predict all their potential target sites in the
genome.
Given the importance of understanding the basis of molecular
recognition between DNA and its ligands, several methods have
been developed to determine the sequence specificity of DNA-
binding molecules (small molecules as well as proteins). The most
frequently used approach is the systematic evolution of ligands by
exponential enrichment (SELEX), which utilizes selection and
enrichment of the DNA sequences that bind with the highest
affinity to a molecule of interest (4). This assay, although highly
informative, identifies only the best binding sequences, whereas the
less optimal, and often biologically relevant, sequences are missed.
Other commonly used biochemical or biophysical approaches are
labor-intensive and can be used only to study a limited set of
sequence variants (5–10). Medium-throughput microarrays have
also been developed in which duplex DNA molecules are immo-
bilized on surfaces and protein binding is detected by surface
plasmon resonance (11) or fluorescence (12, 13). Despite such
demonstrations of feasibility, technical challenges have hindered
the general application of these array platforms. A solution-phase
medium-throughput assay utilizes DNA sequence variants pre-
sented in distinct wells and protein or small molecule binding
detected by displacement of a DNA-intercalating fluorescent dye
(14). Each of these medium-throughput approaches, however, is
limited to querying DNA sequences with only three, four, or five
permuted positions.
In a recent approach, a biased microarray bearing only the
intergenic regions of yeast chromosome was used to map transcrip-
tion factor binding sites in vitro (15). These arrays provide a biased
binding profile and are limited to organisms with small and well
annotated genomes. Another technique that circumvents this prob-
lem relies on sonicating genomic DNA into small fragments and
adding a transcription factor to isolate putative binding sites (16).
However, thismethod, like SELEX, is likely to overrepresent strong
binding sites, thereby providing biased sequence-recognition pro-
files. Thesemethods are not amenable to an unbiased analysis of the
binding properties of small molecule DNA ligands.
Chromatin immunoprecipitated (ChIP) DNA analyzed on oli-
gonucleotide microarrays (chip) has also been used to map binding
sites for DNA-binding transcription factors (17–19). Importantly,
ChIP-chip studies have suggested that in vitro affinity of coopera-
tively binding transcription factors for specific DNA sequences is
often recapitulated in the relative occupancy of these sequences in
vivo (20, 21). This observation suggests that for a given transcription
factor (or a set of cooperatively binding factors), the knowledge of
its full sequence-recognition profile,measured in vitro, can be highly
instructive in computationally identifying binding sites in the ge-
nome. Thus far, in the absence of genome-wide binding and
expression data, computational approaches to identifying regula-
tory sites have been limited to phylogenetic comparisons of con-
served noncoding sequences (22). However, unlike proteins, for
most DNA-binding small molecules with unknown DNA-binding
properties, ChIP-chip analysis is nontrivial, and phylogenetic com-
parisons are irrelevant.
To bridge this gap between computational methods and molec-
ular recognition properties of DNA ligands, we have developed a
comprehensive high-throughput platform that can rapidly and
reliably identify the cognate sites of DNA-binding molecules. This
platform provides an unbiased analysis because it consists of a
double-strandedDNAarray that displays the entire sequence space
represented by 8 bp (all possible permutations equal 32,896 mol-
ecules) and can currently be extended to asmany as 10 variable base
pair positions. We have also developed a systematic approach for
treating the array data that can be applied to arrays of greater
complexity. Because most metazoan DNA-binding proteins target
6–10 bp (23), and because DNA-binding small molecules rarely
exceed 8 bp (24), our cognate site identifier (CSI) arrays should be
capable of identifying and ranking sequences preferred by almost
anyDNA-binding ligand by itself, or, inmany cases, in cooperatively
binding pairs.Our approach derives comprehensive binding profiles
from a rapid, unbiased, and unsupervised examination of the entire
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DNA sequence space. These analyses can be extended to DNA-
binding proteins from any organism or, in the case of small
molecules, used to predict binding sites in any genome.
Results
Array Design. The duplex DNA sequences are designed as self-
complementary palindromes interrupted at the center by a TCCT
sequence to facilitate the formation of DNA hairpins (Fig. 1). The
34-residue oligonucleotide is synthesized directly on the glass
surface by using a maskless array synthesizer (25) that can readily
create up to 786,000 spatially resolved features. After inducing
hairpin formation, we found that 95%of the oligonucleotides in the
array form duplexes (see Materials and Methods). In our hairpin
design, we added three constant base pairs on either side of the 8
bp that were permuted (N1–N8 in Fig. 1). Previous work shows that
this addition is sufficient to buffer the core of the hairpin stem
against thermal end-fraying of the duplex and against deviations
from B-form DNA resulting from the presence of the loop (26).
There is good evidence that the core of a hairpin stem interacts with
proteins and small molecule ligands indistinguishably from DNA
duplexes composed of two individual complementary strands
(27, 28).
Array Validation Using an Engineered Small Molecule. To test the
accuracy and fidelity of the CSI array, we used a polyamide
engineered to target a specific DNA sequence (PA1, Fig. 2A).
Polyamides are DNA-binding small molecules composed of N-
methylpyrrole (Py) and N-methylimidazole (Im) heterocycle rings.
The arrangement of the heterocycles (Im or Py) can be pro-
grammed to create polyamides that target most naturally occurring
6- to 8-bp DNA sequences (2). PA1, in particular, was designed to
target the sequence 5-WWGWWCWW-3 (W  A or T) (Fig. 2)
(29). A Cy3 fluorescent dye is conjugated to the N-methyl position
of an internal pyrrole (Py*). Such conjugation does not meaning-
fully alter the DNA-binding properties of the polyamides (30).
Previous solution-based footprinting (29) and dye displacement
assays (28) have shown that polyamides discriminate very highly
between their targeted cognate site and sites that differ by a single
base pair. Thus, PA1, a well characterized DNA-binding molecule,
serves as a stringent test for the ability of the CSI array to accurately
identify its sequence recognition landscape.
PA1 was incubated with the array and a distinct pattern of
fluorescent binding features was readily discernible, and the pattern
did not change over a broad range of PA1 concentrations (0.5–500
nM). The array-to-array variability was very low, with an average
correlation coefficient of 0.88 (Fig. 6, which is published as sup-
porting information on the PNAS web site). A majority of the
features showed low background fluorescence, and a small subset
of the features were of high intensity (Fig. 2B and Fig. 7, which is
published as supporting information on the PNAS web site). The
duplicate features within an array and replicate features between
arrays were averaged together to give finalized intensities. These
averaged intensities were then converted into Z scores [Z 
signal  meanstandard deviation] to reflect the signal-to-noise
ratio (Fig. 2B).
Sequences in the highest Z score bin (25) were subjected to
several motif-searching algorithms (31–33), which identified 5-
Fig. 1. Illustration of a CSI microarray and the exper-
imental approach. Each hairpin probe is composed of
a permuted hairpin stem (N1–N8) with a 3-bp flanking
sequence (CGC) on either side. N represents the exact
complement to the permuted (N) forward sequence. A
fluorescently tagged ligand is applied to the microar-
ray to obtain a comprehensive ligand-binding profile.
In addition to reference grid features, high intensity
features are circled, indicating tight binding of the
ligand to that specific probe sequence.
Fig. 2. CSI profile of PA1. (A) Structure of polyamide-Cy3 conjugate PA1
(ImPy*PyPy--ImPyPyPy--Dp). (B) Histogram of averaged intensities of all
replicate features. Intensities are background-subtracted so that the mean
intensity is zero. Red numbers indicate Z scores. (C) (Top) Logo (53) based on
the sequences from the top Z score bin (Z 25). (Middle) DNA sequence that
would be targeted by PA1 based on the ring pairing rules for polyamides; an
ImPy ring pair targets GC, and a PyPy pair targets either AT or TA (2).
Numbers indicate base pair positions. (Bottom) A ball-and-stick schematic of
PA1. Im or open circle, N-methylimidazole; Py or filled circle, N-methylpyrrole
ring; Py* or open circle with inner dot, N-methylpyrrole ring with a Cy3 dye
attached;  or diamond, -alanine; Dp or a half circle with a positive charge,
dimethylaminopripylamide;  or turn, -aminobutyric acid. (D) Intensity pro-
file of all sequence permutations of the core consensus sequence 5-
WGWWCW-3. The intensities of all probes that contain a specific permutation
of the core consensus sequence are averaged together. (E) Plot of the corre-
lation between CSI intensities and equilibrium association constants (Ka)
determined from nuclease protection (DNase I footprinting) experiments
(Table 1). The intensities of all CSI probe sequences that contain a particular
footprinted sequence are averaged together.
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W1W2G3T4W5C6W7W8-3, a motif that is nearly identical to the
predicted binding site for the polyamide 5-WWGWWCWN-3
(Fig. 2C). Parsing of the core sequences (N2–N7) showed that not
all permutations of the consensus are bound equally well. In
particular, all sequences that contained the sequence 5-
WWGATCWW-3 had significantly lower intensities than other
permutations of the consensus sequence (Fig. 2D). This observa-
tion is consistent with previous solution studies (34). Furthermore,
the flanking sequence (N1,N8) showed an equally strong preference
for a W (AT) in both positions (Fig. 8, which is published as
supporting information on the PNAS web site). This observation is
also in agreement with the preference of the polyamide -ami-
nobutyric acid turn and Dp tail for AT residues (35). Finally, we
found that the cognate site preferences identified by the array were
entirely consistent with reported solution binding studies of this
polyamide for five different sequences (Fig. 2E and Table 1, which
is published as supporting information on the PNAS web site). The
high correlation (r2  0.997) of feature intensity on the array with
affinity for different cognate sites in solution provides significant
confidence in the veracity of the cognate site preferences identified
by the array. Taken together, these correlations demonstrate that
the CSI array correctly identifies the cognate sites of a DNA-
binding molecule, and that the CSI array accurately ranks each
cognate site in the order of increasing affinity.
Comprehensive Mutational Analysis. In essence, the array performs
a comprehensive ‘‘mutational’’ analysis as it queries the entire
sequence space (within a defined size) to determine the contri-
bution of every base pair in the cognate site for molecular
recognition (Fig. 3). By examining the array data, it is apparent
that substituting an S (G or C) at position 8 only subtly decreases
binding by PA1. This finding is consistent with the ability of this
symmetric polyamide to bind the sequence in only one orienta-
tion. Replacing one of the S residues at positions 6 (or 3) with
a W significantly attenuates, but does not abolish, binding.
However, substituting any other position that prefers a W in the
motif with an S residue nearly abolishes binding by PA1 (Fig. 3).
The data also show that despite a double substitution at positions
3 and 6 to W, the resulting AT stretch retains its ability to bind
PA1. This observation is likely a result of the inherent affinity of
polyamides for AT-rich sequences (36).
Transcription Factor Binding and Cooperative Assembly.Having dem-
onstrated the accuracy of the CSI arrays, we probed the sequence
preferences of molecules that bind DNA cooperatively. We exam-
ined the cognate site preference of Exd, a transcription factor that
plays an essential role in Drosophila development and is highly
conserved across species, including humans (37). Exd binds DNA
cooperatively with transcription factors from the Hox (homeobox)
family (37, 38). Individual Hox proteins, as well as Exd, bind DNA
with very low affinity and with poor specificity (38). Cooperative
binding dramatically increases the affinity of Exd and Hox proteins
for DNA and strongly influences DNA sequence specificity such
that different Hox–Exd complexes target different genes (38). We
have generated synthetic molecules (polyamide-peptide conju-
gates) that can mimic two key functions of the Hox family of
transcription factors (39). First, they can bind sites targeted by
specific Hox proteins, and second, they can cooperatively recruit
Exd to an adjacent cognate site.
To determine the sequence specificity of Exd, we labeled it with
Cy3 at a unique cysteine residue on an unstructured portion of the
protein (Fig. 9A, which is published as supporting information on
the PNAS web site.) (40). The modified protein does not differ in
its ability to bind cooperatively with ultrabithorax (Ubx), a member
of theHox family, orwith a syntheticHoxmimic to a known cognate
DNA site. When tested on the CSI array, Exd alone, as expected,
demonstrated little sequence-specific binding at concentrations
ranging from 0.2 to 200 nM. It does, however, show an unexpected
preference for stretches of consecutive G residues (Fig. 9B). Initial
studies suggest that these sequences can form non-B-form, likely
G-quadruplex (41), structures (Fig. 9D). The physiological impor-
tance of this binding interaction remains to be investigated.
When incubated with two different synthetic Hox mimics (PA2
and PA3), the Cy3-labeled Exd displayed an unambiguous pattern
of feature binding in both sets of experiments (Fig. 4). PA2 andPA3
(ImImPy*Py--ImPyPyPy--Dp) are designed to target the se-
quence 5-WGWCCW-3. Furthermore, instead of a Cy3 dye, PA2
and PA3 do not bear any dye but are conjugated to an Exd-binding
peptide (N-FYPWMK-C). PA2 and PA3 differ solely by a single
methylene in the linker connecting the Exd-binding peptide to the
polyamide (Fig. 4A) (42). Because PA2 and PA3 are not fluores-
cently labeled, we detected cognate sites bound cooperatively by
these synthetic Hox mimics and Exd, as well as sites bound by Exd
alone.
The raw array data for the above experiments were treated as
described for Fig. 2 (Fig. 10, which is published as supporting
information on the PNAS web site). In addition to the G-stretches
that Exd binds in the absence of any partner, three clear motifs
emerged from the PA2–Exd data, whereas only two of those
motifs were found in the PA3–Exd data (Fig. 4B). The Exd binding
motif is 5-NGAN-3, which is consistent with the structural and
genetic studies of Hox–Exd cognate sites (43). In other words, the
5-GA-3 dinucleotide is the only required sequence determinant
for Exd binding to DNA. Remarkably, the array identified the
differences in the arrangement of polyamide and Exd binding sites
because of an1.25-Å difference in the linker length between PA2
and PA3 (Fig. 4C). The other important result that emerged is that
cooperative ternary assembly with Exd stabilizes binding of syn-
thetic Hox mimics to truncated sites (5-WGWC-3). This stabili-
zation is often seen in nature, where cooperative assembly of
transcription factors utilizes suboptimal binding sites to ensure that
only a higher order complex can efficiently bind to a regulatory
element (44, 45).
Solution Binding and Molecular Modeling. To validate the unex-
pected differences in the motifs identified by each polyamide with
Exd, we performed EMSAs. These studies with Exd and the two
Hoxmimics strongly support the cognate site preferences identified
by the array (Fig. 5A andC). Furthermore,molecularmodeling (46,
47) analyses of PA2 and PA3 with Exd (with a docked Hox
hexapeptide) agree well with the CSI array data. Both demonstrate
that the linkers for PA2 and PA3 (9.98 and 11.25 Å, respectively)
are able to deliver the hexapeptide to Exd at the composite
consensus site (Fig. 5B). The array data indicate that both PA2 and
PA3 reach Exd at the gapped composite site (consensus 1);
however, simple geometric measurements with some energy min-
Fig. 3. Comprehensive mutational analysis plot of PA1. (Left) Plot of the
relative abundance of each sequence motif in each Z score bin. Relative
abundance is calculated as the number of sequences in each Z score bin that
contain a particular sequence motif divided by the number of total sequences
in that Z score bin. These abundances are then scaled to one. (Right)
Sequences. S  G or C, W  A or T.
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imization (48) suggest that the linker of PA3 should not span the
distance. In the case of inverted binding sites, it is clear from
modeling that the linker of PA3 is incapable of reaching Exd, and
that the linker of PA2, even when fully extended, would be
suboptimal, yielding an unstable ternary complex with Exd. These
predictions are in good agreement with the observed CSI array
binding data and EMSA results (Fig. 5C). However, the array data
also demonstrate that a single base overlap (consensus 1) in the
binding sites is not able to support binding of the complex, despite
the fact that modeling indicates that the distance is similar to that
of the consensus1 site (Fig. 5B). The binding of either partner to
overlapping sites may deform the DNA and prevent complex
formation, even thoughmodeling studies suggest that polyamide or
Exd binding to the consensus 1 site should not disfavor complex
formation (40, 49). Therefore, the ambiguities inmolecular docking
and energy minimizationmethods prevent precise prediction of the
geometry of DNA grooves and distances between the interacting
partners. In otherwords, the dramatic consequences on cognate site
preference because of subtle, seemingly trivial, alterations in the
linker length would not be readily apparent without the CSI array
analysis. Therefore, this approach provides unexpected insight into
molecular recognition properties of DNA-binding molecules when
they bind individually or in cooperative pairs.
Discussion
In the CSI approach, the comprehensive sequence recognition
landscape of DNA-binding molecules is determined in a rapid,
unbiased, and unsupervised manner. Although we have directly
labeled the DNA-binding molecules with a fluorescent dye, we
anticipate that fluorescently labeled antibodies would serve
equally well in detecting target proteins bound to their cognate
sites. Because of the display of entire sequence space (within a
certain size) on the array, there is no limitation on the use of
proteins of a specific organism (as would be the case with
ChIP-chip) or a specific class of small molecule ligands.
Because the CSI array analysis examines the entire sequence
space at once, it also performs a comprehensivemutational analysis
in a single experiment. Thus, one obtains information on the
contribution of each nucleotide residue to the molecular recogni-
tion event between the DNA ligand and its cognate site(s). More-
over, DNA-binding preferences of the ligands (proteins or small
molecules) are queried under identical conditions, yielding high-
quality information. In the future, the accumulation of binding data
fromCSI analysis of different molecules will lead to the elucidation
of the molecular recognition by a cluster of residues displayed on
the surface of DNA-binding molecules. Such integrative perspec-
tive may be necessary to decipher the principles of molecular
recognition displayed by DNA-binding molecules.
By determining the complete sequence recognition profile of
DNA-bindingmolecules, the CSI array analysis also bridges the gap
between the ChIP-chip approach and bioinformatic approaches of
identifying regulatory DNA elements in genomes. For example,
from a single CSI array experiment, one can validate (and order by
affinity) all binding sites identified by ChIP-chip assays. Further-
more, the rank-order of the sequences can be used to computa-
tionally mine the genome for possible binding sites. The CSI array
analysis would enable a coherent analysis of transcriptome studies
by scanning for the presence of a range of possible binding sites in
coregulated genes. Thus, including a CSI analysis in conjunction
with other approaches will greatly aid in reducing the discrepancies
between and absence of discernible binding sites in coregulated
genes or the inability to detect protein binding at all biologically
relevant sites in vivo by ChIP-chip analysis. The CSI array also
provides a much-needed high-throughput approach for the design
and development of novel classes of sequence-specific DNA-
binding molecules.
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Fig. 4. CSI profile data for PA2 and PA3 with
Exd. (A) (Left) Structures of polyamide-
peptide conjugates PA2 and PA3 (ImImPy*Py-
-ImPyPyPy--Dp). The expected DNA-bind-
ing sequence is 5-WGWCCWW-3 based on
the ring-pairing rules for polyamides (2). The
peptide sequence, N-FYPWMK-C, is conju-
gated to Py*. (Right) Schematic of cooperative
binding of polyamide and Exd to DNA. (B)
Logos for the main motifs found in the CSI
profile for PA2-Exd (Left) and PA3-Exd (Cen-
ter) using motif-finding algorithms (31–33).
Logos are based on sequences from the top Z
score bin (Z  5.0). (Right) Representation of
expected binding orientation of Exd and poly-
amide in the motif. Boxes indicate the binding
position of Exd and polyamide in the se-
quence. An underline instead of a box indi-
cates that the polyamide is binding in an in-
verted orientation. (C) Plot of the relative
abundance of each sequence motif in each Z
score bin. (Left) PA2 with Exd. (Right) PA3
with Exd.
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As the ability to display more oligonucleotide features on a
surface increases, the CSI approach can be easily scaled to
represent larger sets of sequence variants. The most current
technology (up to 10 positional variants), which is accessible to
the entire scientific community, is sufficient to determine the
binding preferences of nearly all metazoan DNA-binding pro-
teins and engineered DNA-binding small molecules. Thus, this
platform provides a powerful tool for tackling the important
challenge of deciphering the DNA recognition code of DNA-
binding molecules, individually or in cooperatively assembling
complexes.
Materials and Methods
Duplex DNA Arrays.Microarrays were synthesized by using a Mask-
less Array Synthesizer (NimbleGen Systems, Madison, WI) (25).
Homopolymer (T10) linkers were covalently attached to monohy-
droxysilane glass slides. Oligonucleotides were then synthesized
on the homopolymers to create a high-density oligonucleotide
microarray. The array surface was derivatized such that the density
of oligonucleotides was sufficiently low within the same feature so
that no one oligonucleotide would hybridize with its neighbors.
Four copies of every sequence required a total of 131,584 features
per array.
Hairpin Formation Percentage. In two distinct features on the array
we present two sequences: one that forms a hairpin (5-CGC-
TTAGTTCA-CGC-TCCT-GCG-TGAACTAA-GCG-3) and
one that does not (5-CGC-TTAGTTCA-CGC-3). By using a
Cy3-labeled DNA probe that is complementary to the core
sequence (5-CGC-TTAGTTCA-CGC-3) present in both oli-
gonucleotides, we determined the ability of the complementary
strand to bind the hairpin versus the single-stranded DNA
molecules. The fluorescence intensity of the hairpin sequence
was divided by the fluorescence intensity of the single-stranded
sequence. The averaged background-subtracted intensity ratio
of the double-stranded versus the single-stranded features indi-
cated 95.6% hairpin formation.
Polyamide Synthesis. Polyamide-Cy3 conjugate PA1 was prepared
by employing an orthogonally protectedN-(phthalimidopropyl)pyr-
role building block in standard Boc-based solid-phase synthesis
(50). Cleavage of the polyamide from 100 mg of phenylacet-
amidomethyl (PAM) resin by treatment with 1 ml of dimethylami-
nopropylamine also removed the phthalimide protecting group to
give the free base. The crude cleavage mixture was diluted with
0.1% trifluoroacetic acid (aq) and acetonitrile to a final volume of
5 ml and loaded onto a preconditioned solid-phase extraction
column (C18 bonded phase). After washing with a 4:1 (volvol)
solution of 0.1% trifluoroacetic acid (aq) and acetonitrile, product
was elutedwithmethanol, and solvents were removed by azeotropic
distillation from toluene. The resulting aminopropyl precursor of
PA1was a slightly yellow solid.AnalyticalHPLCandMALDI-TOF
MS verified the identity and purity of this intermediate, and it was
used without further manipulation.
The intermediate free base (0.5 mol) was dissolved in 0.45 ml
of anhydrous dimethylformamide and 0.05 ml of diisopropylethyl-
amine. An amine-reactive Cy3 fluorophore (1 mg) (Amersham
Pharmacia) was added to this solution, and the resulting mixture
was agitated for 4 h. Crude products were purified by preparative
HPLC. The purity and identity of the product was confirmed by
analytical HPLC and MALDI-TOF MS.
PA1. UV-Vis (H2O) max in nm ( in M1cm1): 313 (69,500), 555
(75,000). MALDI-TOF MS (monoisotopic) [M  H] 1,877.60
(1,877.81 calculated for C91H112N24O17S2).
Binding Assay. Microarray slides were immersed in 1 PBS and
placed in a 90°C water bath for 30 min to induce hairpin formation
of the oligonucleotides. Slides were then transferred to a tube of
nonstringent wash buffer (salinesodiumphosphateEDTAbuffer,
pH 7.50.01%Tween 20) and scanned to check for low background
(200 intensity). Microarrays were scanned by using a ScanArray
5000 (GSI Lumonics, Billerica, MA), and the image files were
extracted with GENEPIX PROVersion 3.0 (Axon Instruments, Foster
City, CA).
Polyamide binding.Microarrays prepared as abovewere placed in the
microarray hybridization chamber and washed twice with nonstrin-
gent wash buffer. Polyamide was diluted to 5 nM inHyb buffer (100
mM Mes1 M NaCl20 mM EDTA, pH 7.50.01% Tween 20).
Polyamide (5 nM)was then added to the hybridization chamber and
incubated at room temperature overnight for 16 h. Finally, the
microarrays were washed twice with nonstringent wash buffer and
scanned.
Protein binding. The microarrays were washed with reaction buffer
containing 150 mM potassium glutamate, 50 mM Hepes (pH 7.5),
and 5% glycerol for 5 min. Cy3-labeled Exd (extradenticle) protein
and polyamide were diluted in reaction buffer to a final concen-
tration of 20 nM and 50 nM, respectively. This solution was added
to the hybridization chamber and incubated for 30 min. Subse-
quently, the microarrays were washed with reaction buffer and
scanned.
Data Processing. For each replicate, global mean normalization was
used to ensure the mean intensity of each microarray was the same.
Local mean normalization (51) was then used to ensure that the
intensity was evenly distributed throughout each sector of the
microarray surface. Outliers between replicate features were de-
tected by using the Q test at 90% confidence and filtered out. The
replicates were then quantile-normalized (52) to account for any
possible nonlinearity between arrays. Duplicate features were then
Fig. 5. Solution binding and molecular modeling data. (A) EMSA. (Upper)
PA2 (50 nM) incubated with increasing concentrations of Exd (in nM). (Lower)
PA3 (50 nM) with an Exd titration. Labels above each pair of EMSAs indicate
the binding motif used. The sequences used are shown below each pair of
EMSAs. Boxes indicate the Exd- and polyamide-binding sites. An underline
instead of a box indicates that the polyamide is binding in an inverted
orientation. (B) Molecular models (46, 47) of Exd and polyamide bound in
consensus, consensus1, consensus1, and inverse orientations. Models are
based on aligning the DNA from the Protein Data Bank files 1B8I and 1M18
(47). Distances are calculated from the N-methyl group of the analogous ring
to which the linker is connected on PA2 and PA3 to the carboxyl carbon of the
methionine of the Hox docking peptide (FYPWM) bound to Exd in the crystal
structure. (C) Table listing the Kd calculated from the EMSA and the fluores-
cence intensity (F.I.) extracted from the CSI profile for each polyamide–Exd
complex.
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averaged together. The median of the averaged features was
subtracted to account for background.
Z scoreswere calculated as signalmedianstandard deviation.
Because of the right-handed tail effect, standard deviation of the
background signal was on the basis of the standard deviation from
the median of all signals less than the median. The relationship of
Z scores to P values can be found in Table 2, which is published as
supporting information on the PNAS web site. Motifs were then
found by running several motif-finding algorithms (31–33) on
sequences in the highestZ score bin. Logos (53) of each motif were
then created by using sequences from the highest Z score bin that
contained the motif.
Molecular Modeling.Molecular models were created by aligning the
coordinates of Exd crystallized with DNA (Protein Data Bank ID
code 1B8I) with DNA of hairpin polyamide crystallized with DNA
(Protein Data Bank ID code 1M18) (54). The DNA was aligned at
four different positions by using structural alignment software (46),
creating consensus, consensus 1, consensus 1, and inverse
binding of the polyamide relative to Exd. The distance from the
N-methyl group of the heterocycle ring, which is analogous to
the N-methyl group of the ring of our polyamide that bears the
hexapeptide, to the carboxyl carbon of the methionine of the
recruitment peptide bound to Exd in the crystal structure was then
calculated for each of the four alignments. This calculation dem-
onstrated the distance that the linker in our polyamide (PA2 and
PA3) would have to reach to recruit Exd to DNA (46). The
alignments were visualized by using VMD (Visual Molecular Dy-
namics) software (47). The linkers for PA2 and PA3 were then
drawn and energy was minimized to estimate how far each linker
could likely reach (48).
Dye Conjugation to Exd. A pET3A vector containing the Exd
sequence (residues 1–88) was mutated by using standard quick-
changemutagenesis procedures to replace the cysteinewith a serine
(C41S), and an arginine was replaced with a cysteine (R2C) to
generate Exd R2C (see Fig. 9A and Supporting Methods, which are
published as supporting information on the PNAS web site). This
Exdmutant was found to be stable, and themutation had aminimal
effect onDNAbinding affinity. ExdR2Cwas then labeled with Cy3
by using a Cy3 maleimide Mono-Reactive dye pack (no. PA23031;
Amersham Pharmacia Biosciences). The molar dyeprotein ratio
was determined to be 0.96 (quantified as follows): [Cy3] (A552
dilution factor)150,000 M1cm1; [Exd-R2C]  [A280  (0.08 
A552)]12,090 M1cm1; Dyeprotein  [Cy3][Exd-R2C]; Exd
sequence: 1A(R3C)RKRRNFSK 11QASEILNEYF 21YSHLSNP-
YPS 31EEAKEELARK 41(C3S)GITVSQVSN 51WF-
GNKRIRYK 61KNI.
EMSAs.Forty-merDNAsequences labeledwith 32P (as per standard
methods) were used in all reactions. Reactions were performed in
a buffer containing 150 mM potassium glutamate, 50 mM Hepes
(pH 7.5), 2 mM DTT, 100 ngl BSA, 10% DMSO, and 10%
glycerol. For the binding tests, polyamide-peptide conjugates (50
nM final concentration) and [32P]DNAwere incubated together for
30 min at 4°C. Exd was then added to bring the reaction volume to
20 l. Exd final concentrations were 0.033, 0.1, 0.33, 1, 3.3, 10, 33,
and 100 nM. These reactions were incubated at 4°C for 1 h, and 15
l was loaded onto a prerun 10% acrylamide3% glycerol gel (1
TBE: 90 mM Tris64.6 mM boric acid2.5 mM EDTA, pH 8.3).
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